For General Information, page-1360

Last we were told:

P2B trial "initiated" Q4 2022. We know that EU CTA's are submitted.
Monkey trial dosing in Q4 2022. Expected to not be started yet as no announcement
Combo results due in December 2022. Nothing yet.

I am expecting in Jan: Feedback on CTA in europe, CTA submitted in Aus, Combo results, Monkey update.

Wildscards due, German update for P3 not that it matters too much right now. LGMD trial initiation in animals, does anyone know it will be monkeys or mice? And long covid.

We've also held this 0.10c +- 5% or so for a few weeks now which is encouraging. Lot of biotechs showing a rounded bottom, inflation coming down in US, China gets rid of 0 covid and opens border,

Feels like we've got the word on the word partner on the tip of our tongue and a lot of inflection points coming.

Exciting IMO